LiteVax
Akkersestraat 50
4061Bj Ophemert
NL
LiteVax
Foundation date
24/05/2012
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
LiteVax BV is a biopharmaceutical company focusing on development and exploitation of innovative vaccine adjuvant concepts. Our mission is to contribute to global health by delivering improved adjuvants for vaccines against infectious and noninfectious diseases. People in developed and developing countries will benefit from better vaccines at lower costs.
Upcoming events
All events-
1212 '23
BioFIT 2023
Event by: Eurasanté -
0602 '24
Discovery to Innovation in Animal Health - 2024
Event by: Ghent University, Provaxs, Paul Dick & Associates -
0712 '23
The GxP Academy: Cleaning Validatie
Event by: Advipro
Latest news
More news-
Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China
1 day ago
Read more
-
Celyad announces management change
Friday December 1st 2023
Read more
-
Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States
Thursday November 30th 2023
Read more
Jobs
More jobs-
03/12/23
Limburg
PhD position in the field of neuroimmunology, mouse modelling and induced pluripotent stem cells
Permanent
VIB -
-
01/12/23
Antwerp, Brussels, East Flanders, Hainaut, Liège, Limburg, Luxembourg, Namur, Flemish Brabant, Walloon Brabant, West Flanders
Sales Engineer Belgium
Permanent
Thema Group Belgium
More info?
Ellen Telleir
Communication Coordinator